ARCHIVES

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

AACI To Become More Aggressive In Developing National Issues; Planning To Start on Collaborate Diagnosis Network

July 15, 1983

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999